Universität zu Köln

Journal Article

Grob, J. -J., Amonkar, M. M., Martin-Algarra, S., Demidov, L. V., Goodman, V., Grotzinger, K., Haney, P., Kaempgen, E., Karaszewska, B., Mauch, C., Miller, W. H., Jr., Millward, M., Mirakhur, B., Rutkowski, P., Chiarion-Sileni, V., Swann, S. and Hauschild, A. (2014). Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine. Ann. Oncol., 25 (7). S. 1428 - 1437. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041